# Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

> **NCT02141854** · PHASE3 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 882 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** FS MDPI
- **DRUG:** Fp MDPI
- **DRUG:** Placebo MDPI
- **DRUG:** Albuterol/salmeterol HFA MDI

## Key facts

- **NCT ID:** NCT02141854
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 882 (ACTUAL)
- **Last updated:** 2021-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141854, "Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02141854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*